An innovative study has shown that the release of cytokines and catecholamines, resulting from the interaction of CAR-T cells with the tumor, can be inhibited by catecholamine blockade with Atrial Natriuretic Peptide (ANP) [162]. Here, NPPA is linked to neoplasm.